4th Quarter - Termination

THE CONSILIO GROUP for PARATEK PHARMACEUTICALS

Firm
Client
Income
$24,000
Expenses
—
Terminated
Dec 2, 2024

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, government, and military use

LobbyistCovered position, as disclosed
BRANDON KIRBY —
ETHAN MAHLER —
OLIVER MEISSNER CEO

Contacted: White House Office; HOUSE OF REPRESENTATIVES; U.S. Secret Service; Air Force, Dept of; Defense, Dept of (DOD); SENATE

Defense DEF

Development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, government, and military use

LobbyistCovered position, as disclosed
BRANDON KIRBY —
ETHAN MAHLER —
OLIVER MEISSNER CEO

Contacted: Defense, Dept of (DOD); SENATE; U.S. Secret Service; HOUSE OF REPRESENTATIVES; White House Office; Air Force, Dept of

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.